GEn1E Lifesciences Inc. vs LigniLabs GmbH
GEn1E Lifesciences Inc.
Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Diseases using AI
18 employees · est. 2019 · Palo Alto, United States
GEn1E Lifesciences Inc. is the older company (2019 vs 2022); GEn1E Lifesciences Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | GEn1E Lifesciences Inc. | LigniLabs GmbH |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2022 |
| Headquarters | ||
| Headquarters | Palo Alto, United States | Mainz, Germany |
| Employees | ||
| Employees | 18 larger | 8 |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series A | Seed |
| Total Funding | ||
| Total Funding | $17.03M | $850.00K |
| Funding Rounds | ||
| Funding Rounds | 6 | 2 |
| Services | ||
| Services | Drug development from discovery to clinical trials, Development of novel therapeutics for inflammatory and rare diseases, Utilization of advanced AI platform for drug development | Development of bio-based microencapsulation solutions, Commercialization of lignin-based applications |
| Target Customers | ||
| Target Customers | Patients with inflammatory diseases, Patients with rare diseases, Healthcare providers, Pharmaceutical industry stakeholders | Pharmaceutical companies, Cosmetic manufacturers, Food industry, Agricultural sector |
| Taxonomy | ||
| Taxonomy | AI PlatformDrug DevelopmentImmunomodulatory TherapiesRare DiseasesInflammatory DiseasesMulti-target Company +8 | Biobased SolutionsEncapsulation TechnologyLignin ModificationNanotechnologyMicrotechnologyActive Ingredient Encapsulation +7 |
| Website | ||
| Website | gen1e.com | lignilabs.de |
About GEn1E Lifesciences Inc.
GEn1E Lifesciences Inc. is a clinical-stage company headquartered in the United States that is pioneering the use of AI in drug development, particularly targeting rare and inflammatory diseases. Founded in 2018, GEn1E leverages its proprietary AI platform to expedite the creation of immunomodulator...
About LigniLabs GmbH
LigniLabs GmbH, founded in 2022 and headquartered in Germany, positions itself as "Pioneers in biobased solutions." This innovative startup focuses on exploiting its proprietary micro- and nanotechnology platform to revolutionize the bio-based encapsulation of active ingredients using lignin, a natu...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches GEn1E Lifesciences Inc. and LigniLabs GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when GEn1E Lifesciences Inc. or LigniLabs GmbH moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare GEn1E Lifesciences Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at GEn1E Lifesciences Inc. on 12 Sep 2024, and LigniLabs GmbH on 12 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
